Alfred D. Kingsley - Dec 31, 2022 Form 5 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Stock symbol
LCTX
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/14/2023, 03:16 PM
Previous filing
Dec 27, 2022
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Gift -25K -0.46% 5.43M Dec 1, 2022 Direct F1
holding LCTX Common Shares, no par value 1.04M Dec 31, 2022 By Corporation F2
holding LCTX Common Shares, no par value 375K Dec 31, 2022 By LP F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a gift of 25,000 common shares.
F2 Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
F3 Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.